Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the ran (Q42217198)
Jump to navigation
Jump to search
scientific article published on 27 April 2014
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the ran |
scientific article published on 27 April 2014 |
Statements
1 reference
Dual therapy with lopinavir and ritonavir plus lamivudine versus triple therapy with lopinavir and ritonavir plus two nucleoside reverse transcriptase inhibitors in antiretroviral-therapy-naive adults with HIV-1 infection: 48 week results of the ran (English)
1 reference
Pedro Cahn
1 reference
Jaime Andrade-Villanueva
1 reference
José M Gatell
1 reference
Javier R Lama
1 reference
Michael Norton
1 reference
Patricia Patterson
1 reference
Juan Sierra Madero
1 reference
Maria Inés Figueroa
1 reference
Maria José Rolon
1 reference
GARDEL Study Group
1 reference
27 April 2014
1 reference
1 reference
Identifiers
1 reference